Steven W Lockley, PhD

Brigham & Women's Hospital, Harvard Medical School
Division of Sleep Medicine
RESET study demonstrates that tasimelteon maintains entrainment of melatonin and cortisol in totally blind individuals with non-24-hour circadian rhythms
FP26-6 Tasimelteon Treatment Entrains the Circadian Clock and Demonstrates a Clinically Meaningful Benefit in Totally Blind Individuals With Non-24-Hour Circadian Rhythms